Literature DB >> 10383054

Prosaposin: a myelinotrophic protein that promotes expression of myelin constituents and is secreted after nerve injury.

M Hiraiwa1, W M Campana, A P Mizisin, L Mohiuddin, J S O'Brien.   

Abstract

Recently, we demonstrated that prosaposin and prosaptides (peptides encompassing the neurotrophic sequence in prosaposin) prevent cell death and increase extracellular regulated kinase (ERK) phosphorylation and sulfatide content in primary Schwann cells or oligodendrocytes (Hiraiwa et al., 1997a). Here, we examine the effect of prosaptide on other myelin constituents, on Schwann cell morphology and proliferation, and characterize the time course of expression of prosaposin protein after sciatic nerve injury. After 24 h of treatment with 10 nM TX14(A), a 14-mer prosaptide, the specific activity of UDP-galactose:ceramide galactosyltransferase (GalT) in primary Schwann cells was increased by 150% over controls. Under the same conditions, the maximum content of sulfatide increased 3-fold over controls after 48 h of treatment. Northern blot analysis, probed with oligonucleotide sequences from the GalT and P0 cDNAs, revealed that the mRNA levels of GalT and P0 protein were elevated about 30 and 200%, respectively, over controls after 24 h of treatment with TX14(A). Treatment of primary Schwann cells with TX14(A) also induced a morphological change at 10 nM; the peptide-treated cells had a bipolar (spindle-shaped) appearance after 48 h of treatment, compared to control cells which were irregular and multipolar. TX14(A) did not induce cell proliferation, indicating that TX14(A), unlike IGF-I, is not mitogenic. After sciatic nerve transection, Western blot analysis demonstrated the presence of intact prosaposin in tubular fluid in a silicon chamber into which the proximal and distal nerve stumps were sutured. The concentration of prosaposin in the fluid was maximum after 9 days post-surgery and returned to normal after 28 days post-surgery. In uninjured and injured nerve, prosaposin immunolocalized to the smooth muscle of epineurial and endoneurial vessels. These findings indicated that sciatic nerve secreted prosaposin after injury and that prosaposin is a naturally occurring injury-repair protein which acts to prevent degeneration and to promote regeneration of peripheral nerves.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383054

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  22 in total

1.  Analyses of temporal regulatory elements of the prosaposin gene in transgenic mice.

Authors:  Ying Sun; David P Witte; Peng Jin; Gregory A Grabowski
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

Review 2.  The protective role of prosaposin and its receptors in the nervous system.

Authors:  Rebecca C Meyer; Michelle M Giddens; Brilee M Coleman; Randy A Hall
Journal:  Brain Res       Date:  2014-08-15       Impact factor: 3.252

3.  Evidence for a Role of Nerve Injury in Painful Intervertebral Disc Degeneration: A Cross-Sectional Proteomic Analysis of Human Cerebrospinal Fluid.

Authors:  Tony K Y Lim; Kathleen M Anderson; Pawan Hari; Marcos Di Falco; Troy E Reihsen; George L Wilcox; Kumar G Belani; Sylvie LaBoissiere; Manuel R Pinto; David S Beebe; Lois J Kehl; Laura S Stone
Journal:  J Pain       Date:  2017-06-24       Impact factor: 5.820

4.  J3-crystallin of the jellyfish lens: similarity to saposins.

Authors:  J Piatigorsky; B Norman; L J Dishaw; L Kos; J Horwitz; P J Steinbach; Z Kozmik
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

Review 5.  Prosaposin, a neurotrophic factor, protects neurons against kainic acid-induced neurotoxicity.

Authors:  Hiroaki Nabeka
Journal:  Anat Sci Int       Date:  2021-02-03       Impact factor: 1.741

6.  The exon 8-containing prosaposin gene splice variant is dispensable for mouse development, lysosomal function, and secretion.

Authors:  Tsadok Cohen; Wojtek Auerbach; Liat Ravid; Jacques Bodennec; Amos Fein; Anthony H Futerman; Alexandra L Joyner; Mia Horowitz
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  SAGE analysis of genes differentially expressed in presymptomatic TgSOD1G93A transgenic mice identified cellular processes involved in early stage of ALS pathology.

Authors:  Michel Guipponi; Qiao-Xin Li; Lavinia Hyde; Tim Beissbarth; Gordon K Smyth; Colin L Masters; Hamish S Scott
Journal:  J Mol Neurosci       Date:  2009-12-02       Impact factor: 3.444

8.  Neurolysosomal pathology in human prosaposin deficiency suggests essential neurotrophic function of prosaposin.

Authors:  Jakub Sikora; Klaus Harzer; Milan Elleder
Journal:  Acta Neuropathol       Date:  2006-10-06       Impact factor: 17.088

9.  Impaired prosaposin secretion during nerve regeneration in diabetic rats and protection of nerve regeneration by a prosaposin-derived peptide.

Authors:  Corinne G Jolivalt; Yvonne Vu; Leah M Mizisin; Andrew P Mizisin; Nigel A Calcutt
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

10.  GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin.

Authors:  Rebecca C Meyer; Michelle M Giddens; Stacy A Schaefer; Randy A Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.